2nd Lab Asset and Facility Management in Pharma Europe
Evvnt Promotion / evvnt
Archive
19.03.2024 - 21.03.2024 Steigenberger Airport Hotel, 951 Stationsplein Zuid-West, 1117 CE Schiphol, Noord-Holland, Netherlands
Time: 9:00 AM - 4:00 PM
Conference themes
The last 12 months have highlighted key milestones in European biopharma investment– from GSK injecting €1 million into a 15-building biotech campus in Stevenage, to AstraZeneca investing £1 billion into a new R AND D and Corporate HQ. As the pressure to expand and continue pipeline progression within a scattered and distributed market, there has never been a better time to know how to navigate unknown waters.
The last 12 months have highlighted key milestones in European biopharma investment– from GSK injecting €1 million into a 15-building biotech campus in Stevenage, to AstraZeneca investing £1 billion into a new R AND D and Corporate HQ. As the pressure to expand and continue pipeline progression within a scattered and distributed market, there has never been a better time to know how to navigate unknown waters.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Notes
URL:
Brochure: https://go.evvnt.com/2048864-3?pid=4832
Speakers: Bill Jun, Product Manager – Research and Development, Roche, Francesco Nicolini, Senior Operations Manager, Synthace, and more
URL:
Brochure: https://go.evvnt.com/2048864-3?pid=4832
Speakers: Bill Jun, Product Manager – Research and Development, Roche, Francesco Nicolini, Senior Operations Manager, Synthace, and more
Enquiries and Registration:
https://go.evvnt.com/2048864-2?pid=4832
Ms. Stephanie Nketia
General Medicine
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
